IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 72.440
EU - Europa 39.562
AS - Asia 38.496
SA - Sud America 9.159
AF - Africa 1.052
Continente sconosciuto - Info sul continente non disponibili 157
OC - Oceania 83
Totale 160.949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 68.871
SG - Singapore 14.803
RU - Federazione Russa 10.950
CN - Cina 9.824
GB - Regno Unito 8.411
BR - Brasile 7.130
IT - Italia 6.009
VN - Vietnam 5.974
DE - Germania 2.985
HK - Hong Kong 2.912
UA - Ucraina 2.661
CA - Canada 2.551
FR - Francia 1.605
DK - Danimarca 1.587
FI - Finlandia 1.103
SE - Svezia 1.052
IN - India 890
IE - Irlanda 762
MX - Messico 738
AR - Argentina 709
PL - Polonia 705
BD - Bangladesh 588
NL - Olanda 519
TR - Turchia 498
ID - Indonesia 415
IL - Israele 411
EC - Ecuador 370
ZA - Sudafrica 368
IQ - Iraq 337
ES - Italia 333
JP - Giappone 325
PK - Pakistan 290
CO - Colombia 244
AT - Austria 201
VE - Venezuela 188
MA - Marocco 173
UZ - Uzbekistan 159
EU - Europa 149
CL - Cile 148
SA - Arabia Saudita 130
PY - Paraguay 129
LT - Lituania 125
AE - Emirati Arabi Uniti 122
EG - Egitto 97
PE - Perù 94
PH - Filippine 93
KE - Kenya 91
TN - Tunisia 84
MY - Malesia 73
UY - Uruguay 71
DZ - Algeria 69
JO - Giordania 68
KR - Corea 68
IR - Iran 60
BO - Bolivia 59
BE - Belgio 55
CH - Svizzera 55
AU - Australia 53
SK - Slovacchia (Repubblica Slovacca) 53
AZ - Azerbaigian 48
RO - Romania 45
NP - Nepal 42
CR - Costa Rica 41
CZ - Repubblica Ceca 41
DO - Repubblica Dominicana 40
AL - Albania 39
KZ - Kazakistan 39
PT - Portogallo 37
HN - Honduras 35
JM - Giamaica 34
ET - Etiopia 33
OM - Oman 32
TW - Taiwan 32
TH - Thailandia 30
KG - Kirghizistan 27
NI - Nicaragua 27
HU - Ungheria 25
PA - Panama 24
AM - Armenia 23
GR - Grecia 23
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
TT - Trinidad e Tobago 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NZ - Nuova Zelanda 19
NO - Norvegia 18
LV - Lettonia 17
SI - Slovenia 17
BH - Bahrain 16
QA - Qatar 16
BG - Bulgaria 15
GT - Guatemala 15
BY - Bielorussia 13
HR - Croazia 13
NG - Nigeria 13
MD - Moldavia 12
Totale 160.668
Salva come PNG Salva come JPEG
Città #
Dallas 13.862
Singapore 7.583
Southend 5.518
Ashburn 4.534
San Jose 4.384
Beijing 3.997
Woodbridge 2.868
Hong Kong 2.654
Chandler 2.555
Ann Arbor 2.547
Houston 2.355
Moscow 1.997
Los Angeles 1.984
Fairfield 1.913
San Mateo 1.857
Chicago 1.815
Ho Chi Minh City 1.723
Falls Church 1.553
Seattle 1.330
Dearborn 1.327
Jacksonville 1.205
The Dalles 1.179
Cambridge 1.152
Wilmington 1.148
Hanoi 1.070
Ottawa 946
New York 861
Hefei 806
Lauterbourg 798
São Paulo 760
Salt Lake City 757
Dublin 741
Boardman 740
Buffalo 721
Stevenage 685
Portsmouth 682
Santa Clara 653
Pisa 642
Dong Ket 641
Warsaw 640
Helsinki 555
Lawrence 525
Council Bluffs 489
Milan 455
Brooklyn 445
Beauharnois 444
Tampa 424
Orem 423
Munich 415
Montréal 406
Rome 393
London 368
Elk Grove Village 360
Tel Aviv 356
Montreal 340
Mexico City 325
Frankfurt am Main 296
Tokyo 286
Chennai 267
Denver 252
Rio de Janeiro 250
Johannesburg 235
Stockholm 235
Florence 233
Istanbul 227
Amsterdam 225
Poplar 223
San Diego 222
Da Nang 210
Atlanta 208
Phoenix 206
Haiphong 196
Nuremberg 194
Toronto 172
Sterling 165
Boston 163
Redwood City 161
Old Bridge 158
Lancaster 154
Belo Horizonte 145
Tashkent 144
Brasília 139
Manchester 134
Miami 134
Guangzhou 132
Lappeenranta 132
San Francisco 132
Guayaquil 126
Biên Hòa 123
Ankara 120
Curitiba 119
Central District 114
Turku 113
Quito 111
Porto Alegre 109
Mumbai 108
Baghdad 106
Shenzhen 104
Campinas 101
Washington 101
Totale 99.391
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.831
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.674
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.565
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.330
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 870
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 698
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 597
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 554
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 482
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 466
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 465
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 443
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 406
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 395
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 393
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 384
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 382
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 369
Cartella clinica automatizzata per il reparto di cardiologia 369
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 366
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 365
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 360
A simple echocardiographic score to rule out cardiac amyloidosis 359
An Open System for Managing Long Term ECG Recordings 355
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 351
Building medical knowledge from real world registries: The case of heart failure 343
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 338
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 336
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 335
La neuropatia diabetica 335
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 334
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 330
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 330
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 328
Central sleep apnea and cardiovascular disease state-of-the-art 326
A simple echocardiographic score to rule out cardiac amyloidosis 325
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 323
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 322
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 322
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 321
Treating chemoreflex in heart failure: modulation or demolition? 321
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 320
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 319
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 315
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 314
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 314
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 314
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 312
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 311
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 311
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 309
Adrenergic activation in heart failure: blockade or rebalance? 307
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 307
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 306
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 303
[Central apneas and cardiovascular diseases] 302
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 302
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 302
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 300
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 298
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 298
Prediction of the chemoreflex gain by common clinical variables in heart failure 296
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 295
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 294
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 294
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 293
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 292
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 292
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 292
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 292
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 290
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 289
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 289
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 289
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 287
Effects of smoking in patients treated with cardiac resynchronization therapy 286
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 285
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 283
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 281
Development of an Electronic Medical Record for Patient Care in Cardiology 281
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 281
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 279
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 279
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 279
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 279
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 279
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 279
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 278
[Ten perspectives for research and innovation in cardiac amyloidosis] 277
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 277
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 277
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 277
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 276
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 276
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 275
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 275
Sex-related differences in chronic heart failure 274
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 273
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 273
Totale 38.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 778.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 778.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.325 0 0 0 0 0 0 0 0 0 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202674.941 4.297 13.612 10.203 10.763 8.532 5.113 8.848 3.768 5.099 4.706 0 0
Totale 161.907